Adjuvant FOLFOX Chemotherapy and Splenomegaly in Patients with Stages II–III Colorectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|76|5|363-368

ISSN： 0030-2414

Source： Oncology, Vol.76, Iss.5, 2009-03, pp. : 363-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Administration of adjuvant chemotherapy for stage II‐III colon cancer patients: An European population‐based study

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1480-1489

John Wiley & Sons Inc

Access to resources Recommend Favorite

FOLFOX as Adjuvant Chemotherapy after Curative Resection of Distant Metastases in Patients with Colorectal Cancer

By  

Oncology, Vol. 80, Iss. 1-2, 2011-06 ,pp. : 84-91

Karger

Access to resources Recommend Favorite

Results of Adjuvant FOLFOX Regimens in Stage III Colorectal Cancer Patients: Retrospective Analysis of 667 Patients

By  

Oncology, Vol. 84, Iss. 4, 2013-02 ,pp. : 240-245

Karger

Access to resources Recommend Favorite

Usefulness of the Preoperative Administration of Tegafur Suppositories as Alternative Adjuvant Chemotherapy for Patients with Resectable Stage II or III Colorectal Cancer: A KODK4 Multicenter Randomized Control Trial

By  

Oncology, Vol. 83, Iss. 1, 2012-06 ,pp. : 16-23

Karger

Access to resources Recommend Favorite

Adjuvant Radio-Chemotherapy in Stage II–III Rectal Cancer with 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid: Evaluation of Feasibility

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 476-480

Karger

Access to resources Recommend Favorite